Lilly ALSO published the full phase 2 data at the same time in The Lancet and to say theres some interesting information is almost an understatement
Simple timing framework Baseline Discuss baseline labs before starting, especially with autoimmune disease, gut symptoms, active injury, infection concern, liver disease, kidney disease, or copper concerns
weeks 5 to 8 use 1.5 mg or 4.5 units
A further study investigating tendon-to-bone healing following the transection and detachment of the Achilles tendon in rats went on to reveal that BPC 157 is also capable of promoting tendon-to-bone healing despite the presence of corticosteroids (Krivic et al
Most people stay on the starting dose for at least four weeks
[DOI] [PubMed] [Google Scholar] 35.Stier H: Safety and tolerability of the hexadecapeptide AOD9604 in humans